Ticker Details
Bioventus Inc.
IPO Date:	February 11, 2021
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$613.05M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 3.04%
Avg Daily Range (30 D):	$0.14 | 1.60%
Avg Daily Range (90 D):	$0.14 | 1.76%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.35M
Avg Daily Volume (90 D):	.25M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	47
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	217
Avg Institutional Trade:	$1.34M
Avg Institutional Trade (30 D):	$.75M
Avg Institutional Trade (90 D):	$.75M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.52M
Avg Closing Trade (30 D):	$.73M
Avg Closing Trade (90 D):	$.73M
Avg Closing Volume:	172.35K

News

Mar 12, 2026 @ 7:45 AM Orthobiologics Market to Surpass USD 9 Billion by ... Source: Mordor Intelligence

Aug 4, 2025 @ 12:00 PM Bioventus Enters into a New $400 Million Senior Se... Source: Dave Crawford

Apr 10, 2025 @ 5:30 AM Intramedullary Nail Market size to worth USD 1,537... Source: Coherent Market Insights

Nov 26, 2024 @ 4:00 PM Osteoarthritis Therapeutics Market Size to Reach U... Source: Precedence Research

Oct 4, 2024 @ 9:52 AM U.S. Osteoarthritis Injectables Market Analysis 20... Source: Researchandmarkets.Com

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.34	$.22	$.34
Diluted EPS	$.33	$.21	$.33
Revenue	$568.09M	$157.9M	$568.09M
Gross Profit	$388.16M	$108.78M	$388.16M
Net Income / Loss	$27.27M	$17.32M	$27.27M
Operating Income / Loss	$53.98M	$19.49M	$53.98M
Cost of Revenue	$179.93M	$49.12M	$179.93M
Net Cash Flow	$9.66M	$9.07M	$9.66M
PE Ratio	27.45